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Abstract Öz 
Purpose: Evaluating the technical success, clinical 
outcomes and safety of ultrasound-guided percutaneous 
cholecystostomy (PC) in patients with acute cholecystitis. 
Material and Methods: Medical records of patients 
diagnosed as acute cholecystitis and treated with PC from 
year 2000 to 2011 were retrospectively examined. ASA 
scores, leukocyte counts, gall stone presence, bile cultures, 
additional interventions, interval surgery, procedure-
related complications and mortality were reviewed. 
Results: PC catheters were placed in 127 patients (72 
male, 55 female) aged from 31 to 100 years. Technical 
success of the procedure was 100%. Clinical success was 
obtained in 86% of the patients. No procedure related 
mortality or early major complications were observed. 
Minor complication rate was 7% (9/127) and late major 
complication rate was 3% (4/127). Thirty day in-hospital 
mortality rate was 8% (10/127). Six patients died after 
interval cholecystectomy and 4 patients died before the 
operation. PC served as a definitive treatment in 74% 
(17/23) of the patients with acalculous cholecystitis. Fifty-
eight percent (31/53) of the patients with acute calculous 
cholecystitis were treated only with percutaneous 
cholecystostomy and only 10% (3/31) had recurrent 
cholecystitis in follow up. 
Conclusion: PC can be preferred over primary 
cholecystectomy in acute cholecystitis patients. The 
procedure has high technical success, high clinical 
response and low complication rates. It can also serve as a 
definitive treatment option in patients with high surgical 
risk. 
Amaç: Akut kolesistitli hastalarda ultrasonografi 
kılavuzluğunda perkütan kolesistostomi (PK) işleminin 
teknik başarısı, klinik sonuçları ve güvenilirliğini 
değerlendirmek. 
Gereç ve Yöntem: 2000-2011 yılları arasında akut 
kolesistit tanısı alan ve PK ile tedavi edilen hastaların 
kayıtları retrospektif olarak değerlendirildi. ASA skorları, 
beyaz küre değerleri, safra taşı varlığı, safra kültürleri, ek 
işlemler, elektif cerrahi, işleme bağlı komplikasyonlar ve 
mortalite değerlendirildi. 
Bulgular: Yaşları 31 ile 100 arası 127 hastaya (72 erkek, 55 
kadın) PK kateteri ile tedavi yapıldı. İşlemin teknik başarısı 
%100, klinik başarısı % 86 bulundu. İşleme bağlı mortalite 
veya erken major komplikasyon izlenmedi. Minör 
komplikasyon oranı %7 (9/127) , geç major komplikasyon 
oranı %3 (4/127) olup 30 günde hastanede mortalite oranı 
%8 (10/127) bulundu. Altı hasta elektif kolesistektomi 
sonrası, 4 hasta da PK kateteri takılı durumda öldü. PK ile 
akalkülöz kolesistitli hastaların %74'ünde (17/23) tedavi 
sağlandı ve cerrahi yapılmadı. Akut taşlı kolesistitli 
hastaların % 58'inde (31/53) sadece PK ile tedavi yapıldı 
ve bunların %10'unda (3/31) takipte nüks kolesistit gelişti. 
Sonuç: Akut kolesistit hastalarında PK primer 
kolesistektomiye tercih edilmelidir. İşlem kolay yapılabilir 
bir işlem olup yüksek teknik ve klinik başarı ve düşük 
komplikasyon oranlarına sahiptir. Yüksek cerrahi riski olan 
hastalarda kesin tedavi sağlayabilen bir seçenek olarak 
kullanılabilir. 
Key words: Interventional radiology, ultrasonography, 
acute cholecystitis, cholecystostomy. 
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INTRODUCTION 
Early cholecystectomy is the historic treatment for 
patients suffering acute cholecystitis. Issue with the 
cholecystectomy is its high morbidity up to 41 % 
and high perioperative mortality up to 46 % in the 
elderly and in patients with significant 
comorbidities1-4. Furthermore, morbidity and 
perioperative mortality of early cholecystectomy has 
shown to be higher than delayed elective surgery 
even in the low risk surgical group1, 5. Gall bladder 
drainage with percutaneous catheter placement is 
preferred over early cholecystectomy in our 
institution according to current guidelines6. 
Conventionally, ultrasound guided percutaneous 
cholecystostomy (PC) is used as a bridge therapy to 
overcome a critical period until the patient becomes 
suitable for laparoscopic cholecystectomy7. The 
procedure offers low morbidity and mortality in 
high risk surgical patients. This study aims to 
evaluate the technical success, clinical outcomes and 
complications of PC in patients with acute 
cholecystitis. Besides its effectiveness in bridging to 
delayed cholecystectomy, its role as a definitive 
treatment option is also evaluated.  
MATERIALS AND METHODS  
Patient selection 
The study was conducted in the interventional 
radiology unit of a university teaching hospital and 
approved by the institutional review board of the 
university. The interventional radiology unit had a 
patient population exceeding 6000 per year and 
biliary interventions constituted about 10% of the 
interventions performed. Medical records of acute 
cholecystitis patients who underwent emergency PC 
from year 2000 to 2011 were retrospectively 
examined from the archive database in the 
interventional radiology unit and the hospital 
records by the attendant residents. Patient 
characteristics, co-morbidities, American Society of 
Anesthesiologists (ASA) scores, leukocyte counts, 
presence of gall stones, bile cultures, presence of 
additional interventions, procedure-related 
complications and mortality were reviewed from the 
hospital database for data collection. Patients with 
clinical diagnosis of acute cholecystitis who  
 
underwent PC procedure were evaluated. The 
treatment of patients with PC was based on 
attending clinicians’ preference. All patients with 
increased gallbladder wall thickness and/or 
pericholecystic fluid were included in the study 
group. Patients’ without any radiologic sign of acute 
cholecystitis were excluded owing to the possibility 
of misdiagnosis, thus misinterpretation in clinical 
success of PC. Furthermore, all patients with 
missing information regarding clinical response or 
follow-up were excluded.   
All procedures performed in this study were in 
accordance with the ethical standards of the 
institutional research board and with the 1964 
Helsinki declaration and its later amendments. The 
study was approved by the institution’s research 
board (project no: KA11/129). Informed consents 
regarding procedures and approval to use the data in 
clinical investigations were obtained from all 
patients included in the study group. All data were 
collected by the interventional radiology residents 
and  
Technique 
After obtaining informed consents, PC procedures 
were performed by an interventional radiologist 
under ultrasound guidance. Transhepatic approach 
using the Seldinger technique described by Akhan 
O, et al. was preferred in majority of the cases7. 
Transperitoneal route was used in case of bleeding 
diathesis. Intravenous midazolam and fentanyl 
citrate were used for sedation and analgesia in 
agitated patients. After administration of local 
anesthetic (2% prilocaine), 8 to 12-French locking 
pigtail drainage catheters (Flexima APDL, Boston 
Scientific) were placed in the gallbladder. Clinical 
success of PC was assessed by the decrease in white 
blood cell count and resolution of symptoms as 
described in the clinicians’ follow-up8. Catheters 
were followed up on gravity drainage and were not 
removed for at least 3 weeks for tract maturation to 
occur. Control cholecystograms were obtained at 3, 
7 and 21 days to evaluate the passage through the 
cystic duct and common bile duct. Catheters were 
withdrawn in case of symptom recovery and 
unobstructed passage to the duodenum after 3 
weeks. All patients were followed up with the 
drainage catheter until elective surgery in case of 
obstructed passage. 
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Statistical analysis 
Measured values were reported as percentages or 
means. 
RESULTS 
A total of 127 patients (55 female, 72 male) with a 
mean age of 72 years (range 31 to 100 years) were 
retrospectively reviewed. One hundred four patients 
had gallstones and 23 had acalculous cholecystitis. 
Accompanying co-morbidities were as follows; 
hypertension in 84, diabetes mellitus in 34, chronic 
obstructive pulmonary disease in 19, congestive 
heart failure in 15, chronic renal failure in 15, 
coronary artery disease in 14, advanced stage 
malignancy in 13 and history of stroke in 12 
patients. Seven of the patients had accompanying 
pancreatitis and one had sepsis at the time of 
admission. Surgical risk classification of the patients 
were as follows; ASA II: 57, ASA III: 44 and ASA 
IV: 26 patients. All ASA II patients subject to 
percutaneous cholecystostomy were elderly patients 
(age range, 74 to 100 years) with mild co-
morbidities. 
Mean drainage duration was 32 days (range, 21 to 60 
days). Follow-up with cholecystography was 
performed in 105 of the patients; bile flow to the 
duodenum was present in 81 patients and 
obstruction was diagnosed in 24 of the patients. Ten 
of the 81 patients with unobstructed bile flow to the 
duodenum (12%) underwent elective 
cholecystectomy. Among the patients with 
unobstructed bile flow that were not operated 
(n=71), three patients (4%) required repeat 
cholecystostomy due to recurrent acute cholecystitis 
4 to 12 months after removal of the catheter. 
Twelve of the patients with obstruction (50%) 
underwent elective cholecystectomy and one died 
within the first week due to a reason of present 
malignancy (4%). Three patients (13%) with biliary 
obstruction revealed bile flow to the duodenum 
during follow-up thus were not operated and had no 
symptomatic recurrence after their catheters were 
withdrawn. Eight of the patients with obstruction 
who were discharged from the hospital after 
symptoms subside were lost to follow-up (33%). 
Bile cultures were obtained from all cases and 67 of 
them (53%) were positive. The most common 
pathogen was eschericia coli (n=32) followed by 
enterococcus species (n=18), klebsiella species 
(n=10), pseudomonas aeruginosa (n=5), and 
acinetobacter baumanii (n=2).  
PC was performed successfully in all patients. No 
early major complications such as major bleeding, 
bowel perforation and procedure-related deaths 
occurred. Late major complication rate was 3% 
(n=4). One patient suffered sepsis leading to death 
at the twenty second day of cholecystostomy 
placement, one patient suffered a cutaneous fistula 
and two patients suffered choledocho-duodenal 
fistulas. Patients with choledocho-duodenal fistula 
were successfully treated with percutaneous biliary 
drainage followed by plastic biliary stent placement. 
Minor complication rate was 7% and they were bile 
leaks after catheter dislodgement (n=4) or leakage 
adjacent the catheters (n=5). These cases were 
treated with replacement of the catheter with a 
larger size. 
Clinical success of PC was assessed by white blood 
cell count and resolution of symptoms. Ninety-three 
of the 127 patients (73%) had leukocytosis at the 
time of admission (mean: 14812/ μl, range:7200- 
22200/μl) and 86% of the patients (n=80) showed 
normal leukocyte counts (mean: 8233, range: 4720 
to 13400/μl) within 72 hours after the procedures. 
Leukocytosis persisted in six patients with 
accompanying abscesses, four patients with acute 
pancreatitis and one patient with pancreatic 
malignancy. Mean hospitalization time was 8.3 days 
(range 2 to 58 days). Thirty day in-hospital mortality 
rate was 8% (n=10). There were no technique 
related deaths.  
Fifty-seven patients were operated following 
percutaneous cholecystostomy. Mean time interval 
from the PC to the surgery was 89 days (range 5 
days to 24 months). Six of 21 patients (29%) 
operated within 1 month died after the operation. 
Seventy patients were not operated. Four of these 
patients (6%) died due to sepsis (n=2), multi organ 
failure due to present malignancy (n=1) and cardiac 
failure (n=1) within one month after 
cholecystostomy placement. Additional 
percutaneous interventions had to be performed in 
27 of the patients. Accompanying seven bilomas 
and two abscesses due to bile leak and seven fluid 
collections due to concurrent pancreatitis were 
treated with percutaneous catheter placement. Four 
patients with dislodged catheters underwent re-
catheterization because symptoms did not resolve 
completely. Three patients with acute calculous 
cholecystitis experienced recurrent acute 
 467 
Cilt/Volume 42 Yıl/Year 2017       Cholecystostomy in acute cholecystitis  
 
cholecystitis and were re-catheterized four to twelve 
months after catheter withdrawal. Three patients 
with fistula formation were treated with biliary 
drainage followed by biliary stent placement. 
Pericholecystic fluid collection in one patient with 
gall stone ileus was drained with catheter placement. 
DISCUSSION 
PC has been used as an effective procedure for 
emergency decompression of the infected gall 
bladder in high surgical risk patients since its first 
therapeutic use in 19803. It is found to be a safe 
procedure with clinical improvement rates ranging 
from 56 to 100%7,8. We reported our ten year 
experience in this article. All the procedures were 
technically successful, revealing a clinical 
improvement rate of 86% with no technique related 
deaths or major complications which is consistent 
with the literature3,7,9-11. Transhepatic PC was 
defined with risks of major hemorrhage, hemo-
biliary fistula formation or pneumothorax in 
previous studies3,7. Nevertheless, transhepatic route 
should be the primary option and transperitoneal 
route should be reserved for cases with severe liver 
disease and coagulopathy given that no such 
technique related complications occurred in our 
study of 127 cases7.  
Early complications of percutaneous 
cholecystectomy are defined as bleeding, vagal 
reactions, sepsis, biliary peritonitis, pneumothorax 
and bowel perforation3. No early complications 
occurred in this study. We had two patients with 
sepsis; one of them had sepsis at admission and the 
other developed sepsis 22 days after catheter 
placement thus not regarded as an early 
complication of the procedure. Late complications 
were catheter dislodgement in four patients who 
were re-catheterized with uneventful follow-ups 
after then. Three patients with acute calculous 
cholecystitis experienced recurrent acute 
cholecystitis and were re-catheterized after 4 to 12 
months after catheter withdrawal. 
Major complication rates of percutaneous 
cholecystostomy ranges between 3 to 8% and minor 
complication rates between 4 to 13% in various 
studies3,12,13. Our study revealed 4% major and 7% 
minor complication rates, comparable to previous 
studies. Two of the major and all minor 
complications were treated successfully with 
percutaneous interventions. Only one patient with 
the cutaneous fistula and one patient with sepsis 
were not treated with percutaneous procedures. 
Historical treatment for acute acalculous 
cholecystitis has been cholecystectomy. Recently, 
some studies support PC to be the definitive 
treatment for acute acalculous cholecystitis. The 
number of patients range from 7 to 28 and recurren 
ce rates range from 0 to 7% in these studies13-16. In 
our study, 17 of 23 patients (74%) with acalculous 
cholecystitis were treated successfully with 
percutaneous cholecystostomy alone and none of 
them suffered recurrent cholecystitis. However, 
previous studies and our study consisted of limited 
cases. Therefore, more studies are necessary to 
conclude that PC should be the treatment of choice 
in acalculous cholecystitis patients. 
Fifty-three of 104 patients (51%) with gallstones and 
unobstructed bile flow to duodenum did not 
undergo elective cholecystectomy. Thirty-one of 
these 53 patients (58%) did not suffer any 
complications or recurrent cholecystitis. One-month 
mortality rate of acute calculous cholecystitis 
patients with interval cholecystectomy (12%) was 
more than patients who were not operated (6%). 
Considering that only 6% of the patients (3/53) who 
were not operated had recurrent cholecystitis, and 
mortality rate of 51 patients with elective 
cholecystectomy is 12% (n=6), PC may be sufficient 
to treat patients in cases elective surgery bear high 
risk. However, randomized data are necessary to 
obtain more objective results.   
Limitations of this study substantially relate to its 
retrospective nature leading to incomplete data 
acquisition, especially regarding signs and symptoms 
of acute cholecystitis before and after the 
procedures. The population in the study was 
composed of different age groups and ASA risk 
scores. This fact is considered a limitation revealing 
higher clinical success rates than it should be, 
however it is also important because the results 
correlate well with the general population. 
To conclude; PC through transhepatic approach can 
be preferred to primary cholecystectomy owing to 
high technical success, high clinical response and 
low complication rates. Sole use of PC to treat acute 
cholecystitis is promising however more studies with 
randomized data are still necessary. 
REFERENCES 
1. Houghton PW, Jenkinson LR, Donaldson LA. 
 468 
Yıldırım et al. Cukurova Medical Journal 
 
Cholecystectomy in the elderly: a prospective study. 
Br J Surg. 1985;72:220–2. 
2. Akinci D, Akhan O, Ozmen M, Peynircioğlu B, 
Ozkan O. Outcomes of percutaneous 
cholecystostomy in patients with high surgical risk. 
Tani Girisim Radyol. 2004;10:323-7. 
3. Steiner CA, Bass EB, Talamini MA, Pitt HA, 
Steinberg EP. Surgical rates and operative mortality 
for open and laparoscopic cholecystectomy in 
Maryland. N Engl J Med. 1994;330:403-8. 
4. Huber DF, Martin EW, Jr., Cooperman M. 
Cholecystectomy in elderly patients. Am J Surg. 
1983;146:719–22. 
5. Byrne MF, Suhocki P, Mitchell RM, Pappas TN, 
Stiffler HL, Jowell PS et al. Percutaneous 
cholecystostomy in patients with acute cholecystitis: 
experience of 45 patients at a US referral center. J 
Am Coll Surg. 2003;197:206-11. 
6. Yamashita Y, Takada T, Kawarada Y, Nimura Y, 
Hirota M, Miura F et al. Surgical treatment of 
patients with acute cholecystitis: Tokyo Guidelines. J 
Hepato Biliary Pancreat Surg. 2007;14:91-7. 
7. Akhan O, Akinci D, Ozmen MN. Percutaneous 
cholecystostomy. Eur J Radiol. 2002;43:229-36.  
8. Hsieh YC, Chen CK, Su CW, Chan CC, Huo TI, Liu 
CJ et al. Outcome after percutaneous 
cholecystostomy for acute cholecystitis: a single-
center experience. J Gastrointest Surg. 2012;16:1860-
8. 
9. Gumus B. Percutaneous cholecystostomy as a first-
line therapy in chronic hemodialysis patients with 
acute cholecystitis with midterm follow-up. 
Cardiovasc Intervent Radiol. 2011;34:362-8. 
10. McKay A, Abulfaraj M, Lipschitz J. Short- and long-
term outcomes following percutaneous 
cholecystostomy for acute cholecystitis in high-risk 
patients. Surg Endosc. 2012;26:1343-51. 
11. Melloul E, Denys A, Demartines N, Calmes JM, 
Schafer M. Percutaneous drainage versus emergency 
cholecystectomy for the treatment of acute 
cholecystitis in critically ill patients: does it matter? 
World J Surg. 2011;35:826-33.  
12. van Overhagen H, Meyers H, Tilanus HW, Jeekel J, 
Lameris JS. Percutaneous cholecystectomy for 
patients with acute cholecystitis and an increased 
surgical risk. Cardiovasc Intervent Radiol. 
1996;19:72-6. 
13. VanSonnenberg E, D’Agostino HB, Goodacre BW, 
Sanchez RB, Casola G. Percutaneous gallbladder 
puncture and cholecystostomy: results, complications 
and caveats for safety. Radiology. 1992;183:163-70. 
14. Chung YH, Choi ER, Kim KM, Kim MJ, Lee JK, 
Lee KT et al. Can percutaneous cholecystostomy be 
a definitive management for acute acalculous 
cholecystitis? J Clin Gastroenterol. 2012;46:216-9. 
15. Shirai Y, Tsukada K, Kawaguchi H, Ohtani T, Muto 
T, Hatakeyama K. Percutaneous transhepatic 
cholecystostomy for acute acalculous cholecystitis. Br 
J Surg. 1993;80:1440–2. 
16. Granlund A, Karlson BM, Elvin A, Rasmussen I. 
Ultrasound-guided percutaneous cholecystostomy in 
high-risk surgical patients. Langenbecks Arch Surg. 
2001;386:212-7.  
 
 
 469 
